BioCentury | Apr 21, 2017
Financial News

Synpromics completes venture financing

...raised £5.2 million ($6.5 million) on April 19 in a venture round from existing investors Calculus Capital...
BioCentury | Sep 12, 2016
Financial News

C4X Discovery proposes placing

...L5 million ($6.7 million) Shares: 4.9 million Price: 102p Shares outstanding prior: 32.5 million Investors: Calculus Capital...
BioCentury | Jul 18, 2016
Financial News

Epistem completes placing

...Shares: 8.1 million Price: 80p Shares after offering: 18.7 million Placement agent: Peel Hunt Investors: Calculus Capital...
BioCentury | Jun 27, 2016
Financial News

Epistem proposes placing

...Shares: 8.1 million Price: 80p Shares outstanding prior: 10.6 million Placement agent: Peel Hunt Investors: Calculus Capital...
BioCentury | Mar 24, 2014
Finance

AIMing for services

...CEO Jonathan Milner; DFJ Esprit; MVM Life Science; Roche Venture Fund; Providence Investment; Wren Capital; Calculus Capital...
BioCentury | Aug 5, 2013
Financial News

Scancell completes placing and open offer

...Note: The offering comprises £4.5 million ($6.9 million) in a placing to funds managed by Calculus Capital...
BioCentury | Jul 15, 2013
Financial News

Scancell proposes placing and open offer

...offering comprises up to £4.5 million ($6.7 million) in a placing to funds managed by Calculus Capital...
BioCentury | Jun 10, 2013
Financial News

Horizon Discovery financial update

...MVM Life Science; Roche Venture Fund; Providence Investment; and private investors. New investors Wren Capital; Calculus Capital...
Items per page:
1 - 8 of 8
BioCentury | Apr 21, 2017
Financial News

Synpromics completes venture financing

...raised £5.2 million ($6.5 million) on April 19 in a venture round from existing investors Calculus Capital...
BioCentury | Sep 12, 2016
Financial News

C4X Discovery proposes placing

...L5 million ($6.7 million) Shares: 4.9 million Price: 102p Shares outstanding prior: 32.5 million Investors: Calculus Capital...
BioCentury | Jul 18, 2016
Financial News

Epistem completes placing

...Shares: 8.1 million Price: 80p Shares after offering: 18.7 million Placement agent: Peel Hunt Investors: Calculus Capital...
BioCentury | Jun 27, 2016
Financial News

Epistem proposes placing

...Shares: 8.1 million Price: 80p Shares outstanding prior: 10.6 million Placement agent: Peel Hunt Investors: Calculus Capital...
BioCentury | Mar 24, 2014
Finance

AIMing for services

...CEO Jonathan Milner; DFJ Esprit; MVM Life Science; Roche Venture Fund; Providence Investment; Wren Capital; Calculus Capital...
BioCentury | Aug 5, 2013
Financial News

Scancell completes placing and open offer

...Note: The offering comprises £4.5 million ($6.9 million) in a placing to funds managed by Calculus Capital...
BioCentury | Jul 15, 2013
Financial News

Scancell proposes placing and open offer

...offering comprises up to £4.5 million ($6.7 million) in a placing to funds managed by Calculus Capital...
BioCentury | Jun 10, 2013
Financial News

Horizon Discovery financial update

...MVM Life Science; Roche Venture Fund; Providence Investment; and private investors. New investors Wren Capital; Calculus Capital...
Items per page:
1 - 8 of 8